Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-043972

General Counsel and Secretary sold 3,185 shares at $41.23 ($131,318)

  • General Counsel and Secretary acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2025-03-20 Option exercise +6,250 84,914 D
KASINGER JAMES R. General Counsel and Secretary 2025-03-21 Sale −3,185 $41.23 $131,318 81,729 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2025-03-20 Option exercise · Restricted Stock Units −6,250 18,750 D
Open-market sales · 3,185 sh · avg $41.23 · $131,318
Loading xslF345X05/ownership.xml…